Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Dis Markers
Hoofdauteurs: Castellazzi, Massimiliano, Delbue, Serena, Elia, Francesca, Gastaldi, Matteo, Franciotta, Diego, Rizzo, Roberta, Bellini, Tiziana, Bergamaschi, Roberto, Granieri, Enrico, Fainardi, Enrico
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2015
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4460255/
https://ncbi.nlm.nih.gov/pubmed/26101453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/901312
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items